Common Genetic Variants of Response to Hepatitis B Vaccines Correlate with Risks of Chronic Infection of Hepatitis B Virus: A Community-Based Case-Control Study
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24119741 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Tzu-Wei Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, MacKay Medical College, New Taipei City 252, Taiwan. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Council of Science and Technology of Taiwan, MacKay Medical College.
Abstract (Originalsprache)
Hepatitis B (HB) vaccination effectively reduces the risks of chronic infection with the hepatitis B virus (HBV). It is unknown whether there is a common genetic determinant for response to the HB vaccine and susceptibility to chronic HBV infection. This case-control study, which included 193 chronic HBV carriers and 495 non-carriers, aimed to explore the effects of the most significant single nucleotide polymorphisms (SNPs) in response to the HB vaccine on the risks of chronic HBV infection. Out of 13 tested SNPs, the genotype distributions of four SNPs at the human leukocyte antigen (HLA) class II region, including rs34039593, rs614348, rs7770370, and rs9277535, were significantly different between HBV carriers and non-carriers. The age-sex-adjusted odds ratios (OR) of chronic HBV infection for rs34039593 TG, rs614348 TC, rs7770370 AA, and rs9277535 AA genotypes were 0.51 (95% confidence interval [CI], 0.33–0.79; p = 0.0028), 0.49 (95% CI, 0.32–0.75; p = 6.5 × 10−4), 0.33 (95% CI, 0.18–0.63; p = 7.4 × 10−4), and 0.31 (95% CI, 0.14–0.70; p = 0.0043), respectively. Multivariable analyses showed that rs614348 TC and rs7770370 AA genotypes were significantly independent protectors against chronic HBV infection. The multivariable-adjusted ORs for subjects with none, either one, or both of the protective genotypes were 1.00 (referent), 0.47 (95% CI: 0.32–0.71; p = 3.0 × 10−4), and 0.16 (95% CI: 0.05–0.54; p = 0.0032), respectively. Among eight HBeAg-positive carriers, only one of them carried a protective genotype. This study shows that response to the HB vaccine and susceptibility to chronic HBV infection share common genetic determinants and indicates that HLA class II members are the main responsible host genetic factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, MacKay Medical College, New Taipei City 252, Taiwan.
- Department of Neurology, MacKay Memorial Hospital, New Taipei City 251, Taiwan.
ORCID-Profile: Li-Yu Wang
Förderung
- Council of Science and Technology of Taiwan
- MacKay Medical College
Zitieren
APA
Wu, T. W., Chou, C. L., Chen, C. F., & Wang, L. Y. (2023). Common Genetic Variants of Response to Hepatitis B Vaccines Correlate with Risks of Chronic Infection of Hepatitis B Virus: A Community-Based Case-Control Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24119741
Vancouver
Wu TW, Chou CL, Chen CF, Wang LY. Common Genetic Variants of Response to Hepatitis B Vaccines Correlate with Risks of Chronic Infection of Hepatitis B Virus: A Community-Based Case-Control Study. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24119741
BibTeX
@article{Wu2023,
author = {Wu, Tzu-Wei and Chou, Chao-Liang and Chen, Chuen-Fei and Wang, Li-Yu},
title = {Common Genetic Variants of Response to Hepatitis B Vaccines Correlate with Risks of Chronic Infection of Hepatitis B Virus: A Community-Based Case-Control Study},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24119741}
}
EUVIMED